Dr. Chong Yin | Medicine | Best Researcher Award

Dr. Chong Yin | Medicine | Best Researcher Award

Dr. Chong Yin | Associate Researcher | Affiliated Hospital of North Sichuan Medical College | China

Academic Background

Chong Yin holds a comprehensive academic background in biotechnology, animal genetics, and biomedical engineering, progressing from a Bachelor of Science degree in Biotechnology to a Ph.D. in Biomedical Engineering. His educational foundation has equipped him with a strong interdisciplinary understanding of molecular biology, genetic research, and biomedical applications. His work has been widely recognized and cited across multiple scientific platforms, with over fifteen hundred citations by more than thirteen hundred documents. His research output spans over fifty documents, reflecting a significant and sustained contribution to the field. With an h-index of twenty-two, as recorded on Scopus and Google Scholar, his influence in osteogenic and molecular biology research continues to grow.

Research Focus

Chong Yin’s research focuses on the molecular mechanisms governing bone biology, particularly osteoporosis, and the development of nucleic acid-based therapeutics. His work integrates phase separation, gene editing, and hydrogel technologies to explore novel strategies for enhancing bone regeneration and repair. He aims to bridge fundamental cellular biology with translational therapies for skeletal diseases, focusing on innovative approaches for osteogenic differentiation and bone metabolism.

Work Experience

Chong Yin began his professional career as a graduate assistant at the University of Mississippi Medical Center, where he contributed to foundational biomedical research. He then undertook postdoctoral research at Northwestern Polytechnical University, further refining his expertise in cellular and molecular biology. He currently serves as an Associate Researcher and Associate Professor at the Affiliated Hospital of North Sichuan Medical College, where he leads multiple research initiatives in bone biology and regenerative medicine.

Key Contributions

Chong Yin has made substantial contributions to understanding osteoblast differentiation, bone formation, and mechanotransduction in skeletal tissues. He has pioneered studies on long noncoding RNAs and microRNAs that regulate bone metabolism and developed biomimetic hydrogels with applications in osteomyelitis treatment. His work has provided valuable insights into the biomechanical mechanisms underlying bone remodeling and the therapeutic potential of RNA-based and hydrogel-mediated interventions.

Awards & Recognition

Chong Yin’s contributions have been recognized with prestigious national and international awards, including grants for young investigators and accolades for innovative research in skeletal disease treatment. His work has garnered recognition for advancing translational approaches in bone biology and regenerative medicine.

Professional Roles & Memberships

He is an active member of multiple scientific societies, including the International Chinese Musculoskeletal Research Society, the Chinese Society of Cell Biology, and the Chinese Anti-cancer Association. He serves as a young editorial member for journals such as iMeta and Burns & Trauma, reflecting his growing influence in scientific publishing and peer review.

Profile

Scopus

Featured Publications

Yin, C., Tian, Y., Yu, Y., et al. Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p. Pharmacol Res.

Yin, C., Tian, Y., Li, D., et al. Long non-coding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p. Iscience.

Hu, L., Yin, C., Chen, D., et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ.

Tian, Y., Zhao, Y., Yin, C., et al. Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery. J Control Release.

Yin, C., Zhang, Y., Hu, L., et al. Mechanical unloading reduces microtubule actin crosslinking factor 1 expression to inhibit β-catenin signaling and osteoblast proliferation. J Cell Physiol.

Impact Statement / Vision

Chong Yin envisions advancing the field of bone biology by translating molecular insights into practical therapies that improve patient outcomes. His research aims to integrate genetic, biochemical, and biomaterial strategies to address skeletal disorders and enhance regenerative medicine approaches, establishing a framework for innovative and clinically relevant treatments.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Full Professor, University of Valencia, Spain

Dr. Vicente Vanaclocha-Vanaclocha  is a renowned Spanish neurosurgeon with over four decades of clinical and academic experience. Recognized for his dedication to advancing neurosurgical techniques, he serves as a Consultant Neurosurgeon at Consorcio Hospital General Universitario de Valencia and a Professor of Neurosurgery at the University of Valencia. Known for his work in spine surgery, brain tumors, and peripheral nerves, he remains an influential figure in both national and international neurosurgical communities.

Publication Profile

🎓 Education Background:

Dr. Vanaclocha began his medical journey at the School of Medicine, Universidad de Valencia (1977–1982), earning his MD degree. He completed his neurosurgery specialization at Hospital Clínico Universitario de Valencia (1983–1987) and pursued a PhD in Neurosurgery from Universidad de Valencia, awarded in 1988. In addition to his medical training, he holds advanced language qualifications: C1 German from Goethe Institut, C1 English from the University of Cambridge, and C2 Català from Junta Qualificadora de Coneiximents de Valencia.

💼 Professional Experience:

His illustrious career includes leadership roles such as Head of Neurosurgery at Clinica Universidad de Navarra (1989–1999) and Consorcio Hospital General Universitario de Valencia (2011–2015). He has also practiced at international institutions, including Groote Schuur Hospital in South Africa (1988–1989), enriching his global neurosurgical perspective. He continues to work in private practice at Hospital Vithas Valencia 9 de Octubre and has previous experience in other prominent hospitals across Spain.

🏅 Awards and Honors:

Dr. Vanaclocha is a respected member of prestigious professional societies, including the American Association of Neurological Surgeons (AANS) since 2017, North American Spine Society (NASS) since 2009, European Association of Neurosurgical Societies (EANS) since 1989, and Sociedad Española de Neurocirugía (SENEC) since 1987. His extensive memberships reflect international recognition of his professional contributions.

🔬 Research Focus:

His research interests span neurosurgery with a specific focus on sacroiliac joint pain, spinal biomechanics, peripheral nerve regeneration, and brain tumor treatment. His recent studies emphasize innovations in implant design, spinal motion preservation, and cerebrospinal fluid management in hemorrhagic conditions.

📝 Conclusion:

Dr. Vicente Vanaclocha-Vanaclocha is a pioneering figure in neurosurgery, blending clinical expertise with innovative research and multilingual communication skills. His impact on spinal surgery and neurotrauma continues to shape both academic inquiry and practical medicine in Europe and beyond.

📚 Top Publications:

Effect of Ti6Al4V Alloy Surface and Porosity on Bone Osseointegration: In Vivo Pilot Study in Rabbits
Materials, 2025
 Cited by: Articles on Crossref (citation data pending as it’s recently published)

Dental Implant with Porous Structure and Anchorage: Design and Bench Testing in a Calf Rib Model Study
Materials, 2025
 Cited by: Articles on Crossref (citation data pending)

New Subperiosteal Dental Implant Design with Finite Element Analysis and Mechanical Validation: A Design Validation Study
Materials, 2025
Cited by: Articles on Crossref (citation data pending)

Can a single basal cistern urokinase bolus help to prevent subarachnoid hemorrhage consequences?
Heliyon, 2024
 Cited by: Articles on Crossref (citation data pending)

Prevertebral Anchored Kevlar Band to Recover Intact Spine Movement Ranges in Lumbar Disc Arthroplasty
Biomedical Materials & Devices, 2024
 Cited by: Articles on SpringerLink (citation data pending)